Stephen Baxter
Stock Analyst at Wells Fargo
(3.03)
# 1,233
Out of 4,873 analysts
179
Total ratings
41.59%
Success rate
0.26%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PNTG The Pennant Group | Maintains: Equal-Weight | $30 → $31 | $29.07 | +6.64% | 1 | Jun 3, 2025 | |
MCK McKesson | Maintains: Equal-Weight | $691 → $766 | $720.82 | +6.27% | 6 | Jun 3, 2025 | |
COR Cencora | Upgrades: Overweight | $274 → $337 | $294.12 | +14.58% | 3 | Jun 3, 2025 | |
CAH Cardinal Health | Upgrades: Overweight | $136 → $179 | $164.21 | +9.01% | 7 | Jun 3, 2025 | |
CYH Community Health Systems | Maintains: Underweight | $2 → $3.5 | $3.39 | +3.24% | 9 | May 29, 2025 | |
HCA HCA Healthcare | Upgrades: Equal-Weight | $320 → $385 | $379.02 | +1.58% | 14 | May 29, 2025 | |
THC Tenet Healthcare | Upgrades: Overweight | $150 → $195 | $171.52 | +13.69% | 13 | May 29, 2025 | |
UNH UnitedHealth Group | Maintains: Overweight | $677 → $351 | $305.62 | +14.85% | 11 | May 14, 2025 | |
BTSG BrightSpring Health Services | Maintains: Overweight | $25 → $27 | $22.89 | +17.96% | 4 | May 13, 2025 | |
AGL agilon health | Maintains: Overweight | $6 → $5 | $2.21 | +126.24% | 7 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $84 | $67.58 | +24.30% | 14 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $20 → $16 | $20.02 | -20.08% | 10 | Mar 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $230 → $225 | $175.20 | +28.42% | 13 | Mar 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $295 → $372 | $294.51 | +26.31% | 17 | Mar 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $72 | $54.05 | +33.21% | 21 | Feb 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $370 → $341 | $316.83 | +7.63% | 7 | Feb 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $483 → $478 | $376.42 | +26.99% | 9 | Jan 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $387 → $290 | $238.79 | +21.45% | 10 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $8.00 | +87.50% | 3 | Apr 29, 2024 |
The Pennant Group
Jun 3, 2025
Maintains: Equal-Weight
Price Target: $30 → $31
Current: $29.07
Upside: +6.64%
McKesson
Jun 3, 2025
Maintains: Equal-Weight
Price Target: $691 → $766
Current: $720.82
Upside: +6.27%
Cencora
Jun 3, 2025
Upgrades: Overweight
Price Target: $274 → $337
Current: $294.12
Upside: +14.58%
Cardinal Health
Jun 3, 2025
Upgrades: Overweight
Price Target: $136 → $179
Current: $164.21
Upside: +9.01%
Community Health Systems
May 29, 2025
Maintains: Underweight
Price Target: $2 → $3.5
Current: $3.39
Upside: +3.24%
HCA Healthcare
May 29, 2025
Upgrades: Equal-Weight
Price Target: $320 → $385
Current: $379.02
Upside: +1.58%
Tenet Healthcare
May 29, 2025
Upgrades: Overweight
Price Target: $150 → $195
Current: $171.52
Upside: +13.69%
UnitedHealth Group
May 14, 2025
Maintains: Overweight
Price Target: $677 → $351
Current: $305.62
Upside: +14.85%
BrightSpring Health Services
May 13, 2025
Maintains: Overweight
Price Target: $25 → $27
Current: $22.89
Upside: +17.96%
agilon health
May 13, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.21
Upside: +126.24%
May 6, 2025
Maintains: Overweight
Price Target: $76 → $84
Current: $67.58
Upside: +24.30%
Mar 13, 2025
Downgrades: Equal-Weight
Price Target: $20 → $16
Current: $20.02
Upside: -20.08%
Mar 10, 2025
Maintains: Overweight
Price Target: $230 → $225
Current: $175.20
Upside: +28.42%
Mar 5, 2025
Upgrades: Overweight
Price Target: $295 → $372
Current: $294.51
Upside: +26.31%
Feb 14, 2025
Maintains: Overweight
Price Target: $76 → $72
Current: $54.05
Upside: +33.21%
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $370 → $341
Current: $316.83
Upside: +7.63%
Jan 28, 2025
Maintains: Overweight
Price Target: $483 → $478
Current: $376.42
Upside: +26.99%
Nov 4, 2024
Maintains: Overweight
Price Target: $387 → $290
Current: $238.79
Upside: +21.45%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $8.00
Upside: +87.50%